EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2025
|出版日期||內容資訊||英文 42 Pages
|EpiCast Report:重度憂鬱症的流行病學預測 EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2025|
|出版日期: 2016年10月14日||內容資訊: 英文 42 Pages||
Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as a mood disorder that may lead to a variety of emotional and physical problems (Mayo Clinic, 2015). MDD is characterized by persistent feelings of sadness, anger, irritability or frustration, loss of interest in activities, and overeating or loss of appetite that can last from days to months, and alternates with episodes of wellness (MedlinePlus, 2015). MDD is a highly debilitating condition associated with substantial morbidity, and an enormous social and economic burden (Kessler and Bromet, 2013). The condition affects the thoughts, feelings, behavior, and physical health of an individual, leading to a range of psychological, physical, and social problems.
In the 7MM, epidemiologists forecast that the 12-month total prevalent cases of MDD will increase from 37,157,683 12-month total prevalent cases in 2015 to 38,142,749 12-month total prevalent cases in 2025, at an Annual Growth Rate (AGR) of 0.27%. The US will have the highest number of 12-month total prevalent cases of MDD among the 7MM throughout the forecast period, while Japan will have the least number of 12-month total prevalent cases of MDD.
Despite the high prevalence of MDD and the enormous disability associated with the disease globally, the use of different diagnostic criteria in epidemiological studies makes it difficult to compare the trends in the 12-month and lifetime total prevalence of MDD across markets. Therefore, it is imperative to conduct epidemiological studies using comparable diagnostic criteria in order to evaluate the real burden and the trends in the 12-month prevalence of MDD in the 7MM.
The report “EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2025 ” provide an overview of the risk factors and global trends of MDD in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of 12-month total prevalent cases of MDD segmented by age (18-19 years, in five-year increments from ages 20-84 years, and ending at ages 85 years and older), sex, and severity in these seven markets.